Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection

Hypertrophic cardiomyopathy (HCM) and heterozygous familial hypercholesterolemia (HeFH), two of the most common genetic cardiovascular disorders, can lead to sudden cardiac death. These conditions could be complicated by concomitant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostics (Basel, Switzerland) Switzerland), 2021, Vol.11 (7)
Hauptverfasser: Marziliano, Nicola, Medoro, Alessandro, Mignogna, Donatella, Saccon, Giovanni, Folzani, Stefano, Reverberi, Claudio, Russo, Claudio, Intrieri, Mariano
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page
container_title Diagnostics (Basel, Switzerland)
container_volume 11
creator Marziliano, Nicola
Medoro, Alessandro
Mignogna, Donatella
Saccon, Giovanni
Folzani, Stefano
Reverberi, Claudio
Russo, Claudio
Intrieri, Mariano
description Hypertrophic cardiomyopathy (HCM) and heterozygous familial hypercholesterolemia (HeFH), two of the most common genetic cardiovascular disorders, can lead to sudden cardiac death. These conditions could be complicated by concomitant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as in the case herein described. A young amateur soccer player died in late October 2020 after a fatal arrhythmia and the autopsy revealed the presence of HCM with diffuse non-obstructive coronary disease. The molecular autopsy revealed a compound condition with a first mutation in the MYH7 gene (p.Arg719Trp) and a second mutation in the LDLR gene (p.Gly343Cys): both have already been described as associated with HCM and HeFH, respectively. In addition, molecular analyses showed the presence of SARS-CoV-2 lineage B.1.1.7 (UK variant with high titer in the myocardium. Co-segregation analysis within the family (n = 19) showed that heterozygous LDLR mutation was maternally inherited, while the heterozygous MYH7 genetic lesion was de novo. All family member carriers of the LDLR mutation (n = 13) had systematic higher LDL plasma concentrations and positive records of cardiac and vascular ischemic events at young age. Considering that HCM mutations are in themselves involved in the predisposition to malignant arrhythmogenicity and HeFH could cause higher risk of cardiac complications in SARS-CoV-2 infection, this case could represent an example of a potential SARS-CoV-2 infection role in triggering or unmasking inherited cardiovascular disease, whose combination might represent the cause of fatal arrhythmia at such a young age. Additionally, it can provide clues in dating the presence of the SARS-CoV-2 lineage B.1.1.7 in Northern Italy in the early phases of the second pandemic wave.
doi_str_mv 10.3390/diagnostics11071229
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2559428208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2559428208</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_25594282083</originalsourceid><addsrcrecordid>eNqVjrFOwzAQhi0EEhX0CVhuTKUmxE6iJGNpKUEqS1MhMVXGcRojJw52MpgH5LlwgIGVu-H-093_6UfoBodBFOXhbSXoqVNmEMxgHKaYkPwMzUiYJn4c4-z8j75Ec2PeQlc5jjKSzNBnOVYV72BNteMw2HA6NG4bDa_g1QKFLR2ohJUxigk6CNWBqqGwPdeDVn0j2I9XtVb1zmvBe3op0iX0wUqfUpwfdL9YQsEHrtWHPanROGQrpHDUbwxrlORmOkveCgrebrPbT_4HaaM42lmzANpVUK72pb9Wzz6BuwC7TuGxqzmbMl2ji5pKw-e_8wp52_vDuvB7rd5HRz-2wjAuJe24S3AkSZLHJCNhFv3j9QvOPHK_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2559428208</pqid></control><display><type>report</type><title>Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Marziliano, Nicola ; Medoro, Alessandro ; Mignogna, Donatella ; Saccon, Giovanni ; Folzani, Stefano ; Reverberi, Claudio ; Russo, Claudio ; Intrieri, Mariano</creator><creatorcontrib>Marziliano, Nicola ; Medoro, Alessandro ; Mignogna, Donatella ; Saccon, Giovanni ; Folzani, Stefano ; Reverberi, Claudio ; Russo, Claudio ; Intrieri, Mariano</creatorcontrib><description>Hypertrophic cardiomyopathy (HCM) and heterozygous familial hypercholesterolemia (HeFH), two of the most common genetic cardiovascular disorders, can lead to sudden cardiac death. These conditions could be complicated by concomitant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as in the case herein described. A young amateur soccer player died in late October 2020 after a fatal arrhythmia and the autopsy revealed the presence of HCM with diffuse non-obstructive coronary disease. The molecular autopsy revealed a compound condition with a first mutation in the MYH7 gene (p.Arg719Trp) and a second mutation in the LDLR gene (p.Gly343Cys): both have already been described as associated with HCM and HeFH, respectively. In addition, molecular analyses showed the presence of SARS-CoV-2 lineage B.1.1.7 (UK variant with high titer in the myocardium. Co-segregation analysis within the family (n = 19) showed that heterozygous LDLR mutation was maternally inherited, while the heterozygous MYH7 genetic lesion was de novo. All family member carriers of the LDLR mutation (n = 13) had systematic higher LDL plasma concentrations and positive records of cardiac and vascular ischemic events at young age. Considering that HCM mutations are in themselves involved in the predisposition to malignant arrhythmogenicity and HeFH could cause higher risk of cardiac complications in SARS-CoV-2 infection, this case could represent an example of a potential SARS-CoV-2 infection role in triggering or unmasking inherited cardiovascular disease, whose combination might represent the cause of fatal arrhythmia at such a young age. Additionally, it can provide clues in dating the presence of the SARS-CoV-2 lineage B.1.1.7 in Northern Italy in the early phases of the second pandemic wave.</description><identifier>ISSN: 2075-4418</identifier><identifier>EISSN: 2075-4418</identifier><identifier>DOI: 10.3390/diagnostics11071229</identifier><language>eng</language><ispartof>Diagnostics (Basel, Switzerland), 2021, Vol.11 (7)</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>778,782,862,4478,27908</link.rule.ids></links><search><creatorcontrib>Marziliano, Nicola</creatorcontrib><creatorcontrib>Medoro, Alessandro</creatorcontrib><creatorcontrib>Mignogna, Donatella</creatorcontrib><creatorcontrib>Saccon, Giovanni</creatorcontrib><creatorcontrib>Folzani, Stefano</creatorcontrib><creatorcontrib>Reverberi, Claudio</creatorcontrib><creatorcontrib>Russo, Claudio</creatorcontrib><creatorcontrib>Intrieri, Mariano</creatorcontrib><title>Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection</title><title>Diagnostics (Basel, Switzerland)</title><description>Hypertrophic cardiomyopathy (HCM) and heterozygous familial hypercholesterolemia (HeFH), two of the most common genetic cardiovascular disorders, can lead to sudden cardiac death. These conditions could be complicated by concomitant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as in the case herein described. A young amateur soccer player died in late October 2020 after a fatal arrhythmia and the autopsy revealed the presence of HCM with diffuse non-obstructive coronary disease. The molecular autopsy revealed a compound condition with a first mutation in the MYH7 gene (p.Arg719Trp) and a second mutation in the LDLR gene (p.Gly343Cys): both have already been described as associated with HCM and HeFH, respectively. In addition, molecular analyses showed the presence of SARS-CoV-2 lineage B.1.1.7 (UK variant with high titer in the myocardium. Co-segregation analysis within the family (n = 19) showed that heterozygous LDLR mutation was maternally inherited, while the heterozygous MYH7 genetic lesion was de novo. All family member carriers of the LDLR mutation (n = 13) had systematic higher LDL plasma concentrations and positive records of cardiac and vascular ischemic events at young age. Considering that HCM mutations are in themselves involved in the predisposition to malignant arrhythmogenicity and HeFH could cause higher risk of cardiac complications in SARS-CoV-2 infection, this case could represent an example of a potential SARS-CoV-2 infection role in triggering or unmasking inherited cardiovascular disease, whose combination might represent the cause of fatal arrhythmia at such a young age. Additionally, it can provide clues in dating the presence of the SARS-CoV-2 lineage B.1.1.7 in Northern Italy in the early phases of the second pandemic wave.</description><issn>2075-4418</issn><issn>2075-4418</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2021</creationdate><recordtype>report</recordtype><recordid>eNqVjrFOwzAQhi0EEhX0CVhuTKUmxE6iJGNpKUEqS1MhMVXGcRojJw52MpgH5LlwgIGVu-H-093_6UfoBodBFOXhbSXoqVNmEMxgHKaYkPwMzUiYJn4c4-z8j75Ec2PeQlc5jjKSzNBnOVYV72BNteMw2HA6NG4bDa_g1QKFLR2ohJUxigk6CNWBqqGwPdeDVn0j2I9XtVb1zmvBe3op0iX0wUqfUpwfdL9YQsEHrtWHPanROGQrpHDUbwxrlORmOkveCgrebrPbT_4HaaM42lmzANpVUK72pb9Wzz6BuwC7TuGxqzmbMl2ji5pKw-e_8wp52_vDuvB7rd5HRz-2wjAuJe24S3AkSZLHJCNhFv3j9QvOPHK_</recordid><startdate>20210707</startdate><enddate>20210707</enddate><creator>Marziliano, Nicola</creator><creator>Medoro, Alessandro</creator><creator>Mignogna, Donatella</creator><creator>Saccon, Giovanni</creator><creator>Folzani, Stefano</creator><creator>Reverberi, Claudio</creator><creator>Russo, Claudio</creator><creator>Intrieri, Mariano</creator><scope>7X8</scope></search><sort><creationdate>20210707</creationdate><title>Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection</title><author>Marziliano, Nicola ; Medoro, Alessandro ; Mignogna, Donatella ; Saccon, Giovanni ; Folzani, Stefano ; Reverberi, Claudio ; Russo, Claudio ; Intrieri, Mariano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_25594282083</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Marziliano, Nicola</creatorcontrib><creatorcontrib>Medoro, Alessandro</creatorcontrib><creatorcontrib>Mignogna, Donatella</creatorcontrib><creatorcontrib>Saccon, Giovanni</creatorcontrib><creatorcontrib>Folzani, Stefano</creatorcontrib><creatorcontrib>Reverberi, Claudio</creatorcontrib><creatorcontrib>Russo, Claudio</creatorcontrib><creatorcontrib>Intrieri, Mariano</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marziliano, Nicola</au><au>Medoro, Alessandro</au><au>Mignogna, Donatella</au><au>Saccon, Giovanni</au><au>Folzani, Stefano</au><au>Reverberi, Claudio</au><au>Russo, Claudio</au><au>Intrieri, Mariano</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection</atitle><jtitle>Diagnostics (Basel, Switzerland)</jtitle><date>2021-07-07</date><risdate>2021</risdate><volume>11</volume><issue>7</issue><issn>2075-4418</issn><eissn>2075-4418</eissn><abstract>Hypertrophic cardiomyopathy (HCM) and heterozygous familial hypercholesterolemia (HeFH), two of the most common genetic cardiovascular disorders, can lead to sudden cardiac death. These conditions could be complicated by concomitant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as in the case herein described. A young amateur soccer player died in late October 2020 after a fatal arrhythmia and the autopsy revealed the presence of HCM with diffuse non-obstructive coronary disease. The molecular autopsy revealed a compound condition with a first mutation in the MYH7 gene (p.Arg719Trp) and a second mutation in the LDLR gene (p.Gly343Cys): both have already been described as associated with HCM and HeFH, respectively. In addition, molecular analyses showed the presence of SARS-CoV-2 lineage B.1.1.7 (UK variant with high titer in the myocardium. Co-segregation analysis within the family (n = 19) showed that heterozygous LDLR mutation was maternally inherited, while the heterozygous MYH7 genetic lesion was de novo. All family member carriers of the LDLR mutation (n = 13) had systematic higher LDL plasma concentrations and positive records of cardiac and vascular ischemic events at young age. Considering that HCM mutations are in themselves involved in the predisposition to malignant arrhythmogenicity and HeFH could cause higher risk of cardiac complications in SARS-CoV-2 infection, this case could represent an example of a potential SARS-CoV-2 infection role in triggering or unmasking inherited cardiovascular disease, whose combination might represent the cause of fatal arrhythmia at such a young age. Additionally, it can provide clues in dating the presence of the SARS-CoV-2 lineage B.1.1.7 in Northern Italy in the early phases of the second pandemic wave.</abstract><doi>10.3390/diagnostics11071229</doi></addata></record>
fulltext fulltext
identifier ISSN: 2075-4418
ispartof Diagnostics (Basel, Switzerland), 2021, Vol.11 (7)
issn 2075-4418
2075-4418
language eng
recordid cdi_proquest_miscellaneous_2559428208
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
title Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A59%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Sudden%20Cardiac%20Death%20Caused%20by%20a%20Fatal%20Association%20of%20Hypertrophic%20Cardiomyopathy%20(MYH7,%20p.Arg719Trp),%20Heterozygous%20Familial%20Hypercholesterolemia%20(LDLR,%20p.Gly343Lys)%20and%20SARS-CoV-2%20B.1.1.7%20Infection&rft.jtitle=Diagnostics%20(Basel,%20Switzerland)&rft.au=Marziliano,%20Nicola&rft.date=2021-07-07&rft.volume=11&rft.issue=7&rft.issn=2075-4418&rft.eissn=2075-4418&rft_id=info:doi/10.3390/diagnostics11071229&rft_dat=%3Cproquest%3E2559428208%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2559428208&rft_id=info:pmid/&rfr_iscdi=true